Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New

class="hearing-section Witnesses class="clear I class=" alt class="left Dr. Jesse Goodman , Chief Scientist, U.S. Food and Drug Admin… read more

class="hearing-section Witnesses class="clear I class=" alt class="left Dr. Jesse Goodman , Chief Scientist, U.S. Food and Drug Administration, Silver Spring, MD class="right http://help.senate.gov/imo/media/doc/Goodman1.pdf" class="pdfDownload File class="clear class="left Dr. Alan Guttmacher , Acting Director, National Institute of Child Health and Human Development, Bethesda, MD class="right http://help.senate.gov/imo/media/doc/Guttmacher.pdf" class="pdfDownload File class="clear II class=" alt class="left Mr. Alex Silver , Founder, Jackson Gabriel Silver Foundation, New York, NY class="right http://help.senate.gov/imo/media/doc/Silver1.pdf" class="pdfDownload File class="clear class="left Mr. John F. Crowley , President and CEO, Amicus Therapeutics, Cranbury, NJ class="right http://help.senate.gov/imo/media/doc/Crowley.pdf" class="pdfDownload File class="clear class=" alt class="left Ms. Diane Edquist Dorman , Vice President for Public close

Video Obtained From the Committee Website
This video was obtained from the Congress and may be encoded at a different quality than C-SPAN uses for hearings covered with its own cameras. Also, the video might not start at the beginning of the hearing and much of the data normally added to the C‑SPAN.org for committee hearings may not be available.
Video not available at this time
Alert me when this program is:

Hosting Organization

More information about

Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New

Program ID:
12952-1
Category:
Senate Committee
Format:
Senate Committee
Location:
SD-430, Dirksen Senate Office Building, Washington, District of Columbia, United States